Long-Term Efficacy and Safety of Multi-Matrix Mesalazine Maintenance Therapy in Pediatric Patients with Ulcerative Colitis

Pediatric Gastroenterology Hepatology & Nutrition 2026 Open access

Read full text
Authors: Toshiaki Shimizu, Daisuke Tokuhara, Shigeo Nishimata, Takashi Ishige, Takahiro Kudo, Masahiro Takatsu, Kanako Nishimura, Akiko Matsuda, Koichi Hayashi, Katsuhiro Arai
DOI: 10.5223/pghn.2026.29.1.44
Cited by: 0
References: 15

Abstract

Purpose: This study aimed to evaluate the efficacy and safety of multi-matrix mesalazine in pediatric patients with ulcerative colitis (UC) in remission. Methods: A multicenter, open-label, uncontrolled study was conducted in Japan, in which multi-matrix mesalazine 40 mg/kg was administered orally once daily for 48 weeks to 23 patients with UC in remission, aged

Fields of Study & Subjects

Inflammatory Bowel Disease Pharmaceutical studies and practices Microscopic Colitis

Publication details

Journal / source
Pediatric Gastroenterology Hepatology & Nutrition
Volume
29
Issue
1
Pages
44–44
Publication date
1 January 2026
Language
EN